CDC Recommends Novavax’s COVID-19 Vaccine For Use In Adolescents Aged 12 Through 17

Reuters (8/22, Khandekar) reports that on Monday, the CDC “signed off on the use of Novavax Inc’s COVID-19 vaccine for adolescents aged 12 through 17,” following the FDA’s “authorization for the vaccine for the age group last week.” The company’s “protein...